Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort.
In a case-control study nested within the EPIC-Oxford cohort, there were no statistically significant differences in the prevalence or titre of antibodies against BK virus measured in plasma taken prior to diagnosis between cases with cancer of the prostate (n=31), kidney (n=5) or bladder (n=9) and controls (n=45).
Newton
R
R
Epidemiology & Genetics Unit, Department of Health Sciences, Heslington, York, UK. Rob.newton@egu.york.ac.uk
Ribeiro
T
T
Casabonne
D
D
Alvarez
E
E
Touzé
A
A
Key
T
T
Coursaget
P
P
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral; D001739:BK Virus / Q000276:immunology / Q000472:pathogenicity*; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000821:virology*; D008297:Male; D008875:Middle Aged; D027601:Polyomavirus Infections / Q000150:complications; D011471:Prostatic Neoplasms / Q000821:virology*; D014412:Tumor Virus Infections / Q000150:complications; D001749:Urinary Bladder Neoplasms / Q000821:virology*
D000914:Antibodies, Viral